PEDIATRICS Vol. 119 No. 6 June 2007, pp. 1165-1174 (doi:10.1542/peds.2006-3124)
ARTICLE |
Patent Ductus Arteriosus and Its Treatment as Risk Factors for Neonatal and Neurodevelopmental Morbidity
a Department of Pediatrics
b Cardiovascular Research Institute, University of California, San Francisco, California
OBJECTIVES. The purpose of this work was to determine whether the reported association between neonatal morbidities and a patent ductus arteriosus is because of the left-to-right patent ductus arteriosus shunt itself, the therapies used to treat it, or the immaturity of the infants who are likely to develop a patent ductus arteriosus.
METHODS. A total of 446 infants (<28 weeks' gestation) were treated with the same patent ductus arteriosus care–oriented protocol, and logistic regression analysis was used to examine the effects of several patent ductus arteriosus–related variables (presence of a symptomatic patent ductus arteriosus, the number of indomethacin doses used, the ductus response to indomethacin, and the use of surgical ligation) on the incidence of retinopathy of prematurity, necrotizing enterocolitis, chronic lung disease, death, and neurodevelopmental impairment.
RESULTS. Most of the predictive effects that the presence of a patent ductus arteriosus and its treatment had on neonatal morbidity could be accounted for by the infants' immature gestation. Use of surgical ligation, however, was significantly associated with the development of chronic lung disease and was independent of immature gestation, other patent ductus arteriosus–related variables, or other perinatal and neonatal risk factors known to be associated with chronic lung disease.
CONCLUSIONS. These findings add to the growing uncertainty about the benefits and risks of surgical ligation during the neonatal period.
Key Words: patent ductus arteriosus indomethacin surgical ligation chronic lung disease necrotizing enterocolitis retinopathy of prematurity neurodevelopmental outcome cognitive outcome neurologic abnormality
Abbreviations: PDA—patent ductus arteriosus NEC—necrotizing enterocolitis CLD—chronic lung disease ROP—retinopathy of prematurity ICH—intracranial hemorrhage MDI—Mental Development Index FSIQ—full-scale IQ OR—odds ratio
Accepted Jan 18, 2007.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
J. Richards, A. Johnson, G. Fox, and M. Campbell A Second Course of Ibuprofen Is Effective in the Closure of a Clinically Significant PDA in ELBW Infants Pediatrics, August 1, 2009; 124(2): e287 - e293. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Vida, P. Lago, S. Salvatori, G. Boccuzzo, M. A. Padalino, O. Milanesi, S. Speggiorin, and G. Stellin Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants? Ann. Thorac. Surg., May 1, 2009; 87(5): 1509 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. McCurnin, R. A. Pierce, B. C. Willis, L. Y. Chang, B. A. Yoder, I. S. Yuhanna, P. L. Ballard, R. I. Clyman, N. Waleh, W. Maniscalco, et al. Postnatal Estradiol Up-regulates Lung Nitric Oxide Synthases and Improves Lung Function in Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., March 15, 2009; 179(6): 492 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Madan, D. Kendrick, J. I. Hagadorn, I. D. Frantz III, and the National Institute of Child Health and Human D Patent Ductus Arteriosus Therapy: Impact on Neonatal and 18-Month Outcome Pediatrics, February 1, 2009; 123(2): 674 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Noori, M. McCoy, P. Friedlich, B. Bright, V. Gottipati, I. Seri, and K. Sekar Failure of Ductus Arteriosus Closure Is Associated With Increased Mortality in Preterm Infants Pediatrics, January 1, 2009; 123(1): e138 - e144. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gien Controversies in the Management of Patent Ductus Arteriosus NeoReviews, October 1, 2008; 9(10): e477 - e482. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. McCurnin, S. Seidner, L.-Y. Chang, N. Waleh, M. Ikegami, J. Petershack, B. Yoder, L. Giavedoni, K. H. Albertine, M. J. Dahl, et al. Ibuprofen-Induced Patent Ductus Arteriosus Closure: Physiologic, Histologic, and Biochemical Effects on the Premature Lung Pediatrics, May 1, 2008; 121(5): 945 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Platt Fantoms Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2007; 92(6): F423 - F423. [Full Text] [PDF] |
||||









